Success Story: Medicine Researcher Secures NIW Approval for Work Advancing Cardiovascular Risk Prediction
Client’s Testimonial:
"I am happy to have Chen as my attorney and benefit from their vast expertise to achieve the most important milestones of my life.”
On May 12th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Graduate Research Assistant in the Field of Medicine (Approval Notice).
General Field: Medicine
Position at the Time of Case Filing: Research Fellow
Country of Origin: Turkey
State of Residence at the Time of Filing: Minnesota
Approval Notice Date: May 12th, 2026
Processing Time: 15 months, 8 days (Premium Processing Upgrade Requested)
Case Summary:
We are pleased to share that North America Immigration Law Group secured I-140 NIW approval for a client working in the field of medicine. The client’s proposed endeavor focused on utilizing machine learning models, genomics, polygenic risk scores, computational biology, and preventive cardiology principles to predict heart disease risks and better extrapolate individual genetic risks in cardiovascular medicine.
The petition framed this endeavor as nationally important because it addressed a major public health challenge. Cardiovascular disease remains a serious health and economic burden, and the client’s work aimed to support more precise risk prediction, earlier intervention, and better individualized care. At the time of filing, the client was employed as a research fellow, where he planned to continue developing machine learning models from health records, studying genetic risk factors, classifying gene variants, and examining factors related to kidney function decline.
To establish that the client was well-positioned to advance the proposed endeavor, the petition highlighted the client’s 3 peer-reviewed journal articles, including 1 first-authored article and 1 co-first-authored article, as well as 3 first-authored abstracts, 1 of which had been accepted. The client’s publications had received 36 citations. We explained that these metrics were meaningful not merely as numbers, but because they showed that other researchers had engaged with and relied upon the client’s work, particularly in studies involving cystic fibrosis treatment safety, cardiovascular evaluation, and genetic factors relevant to medical risk.
Two recommendation letters were submitted to support the petition. These letters helped explain the practical significance of the client’s medical research, the relevance of his prior work to his future endeavor, and the value of his continued contributions to U.S. healthcare and biomedical research.
“In the interest of progressing preventative medicine, particularly in cardiovascular diseases, it is imperative that the country supports his work.”
This approval reflects a petition strategy that connected the client’s publication record, citation impact, current research role, future research plan, and expert support to the Dhanasar framework. Congratulations to the client on this important milestone.